Evidence Table 45: Summary of methods for prospective studies of ambulatory blood pressure measurement (question #3b)

StudyFollow-up-Years mean (SD)NOutcomesAnalyses Adjusted forComparison of Prediction
nOutcomeDescription
Amar, 20002.9 (1.7)5710CVD MortalityIschemic heart disease, Stroke, Aortoiliac disease, Congestive heart failure, Sudden deathAge, Gender, Prior CVDNot Tested
Fagard, a 2000 69579CVD Morbidity and MortalitySudden death, Stroke, MI, Heart failureGender, Prior CVDNot Tested
 29StrokeNeurologic deficit lasting >24 hours or causing death  
Gosse, 19972.5 (0.7)13414CVD Morbidity and MortalityStroke, MI, Angina, Heart failure, Renal failure, Lower limb arterial disease ABP better than Clinic BP, by discriminant function analyses
Nakano, 19994.225722DialysisIncident hemodialysisAge, Gender, Smoking, Blood pressure, Glycemic control, Duration of diabetes, Serum protein, Serum creatinine.ABP better than Clinic BP, by stepwise regression analyses
Ohkubo, b 1997a5.1 (2)154293Total MortalityTotal mortalityAge, Gender, Smoking, Anti hypertensive medications, Prior CVDNot tested
 37CVD MortalityCVD Mortality  
Ohkubo, b 1997b5.1 (2)154293Total MortalityTotal mortalityAge, Gender, Smoking, Anti hypertensive medications, Prior CVDABP better than Clinic BP, by stepwise regression analyses
 37CVD MortalityCVD Mortality  
Ohkubo, b 20006.4 (2)147674StrokeStroke or TIAAge, Gender, Smoking, Cholesterol, Hematocrit, Prior CVD, Diabetes, BP medicationABP better than Clinic BP, by stepwise regression analyses
Perloff, 19895.5 (3.5)761120CVD Morbidity and MortalityCardiac, Cerebral and peripheral vascular diseases, Aortic dissection, Retinal vascular changes, Renal function decline, Heart failureAge, Gender, LVH, BP medication, Optic fundus.Incremental Gain of ABP over clinic BP, by residual model
Redon, 199848621CVD Morbidity and MortalityMI, Angina, Coronary Revascularization, Stroke, TIA, Sudden death, Aortoiliac occlusive disease, Heart failure, Hypertensive emergencies Prior CVDABP better than Clinic BP, by stepwise regression analyses
Staessen, a 19994.4 [median]26539Total MortalityTotal mortalityAge, Gender, Smoking, Prior CVDIncremental Gain of ABP over clinic BP, by regression analyses with both variables entered in models
 22CVD MortalityCVD mortality  
54CVD Morbidity and MortalityFatal and Non fatal heart failure, MI, Sudden death, Stroke  
20StrokeFatal and non fatal stroke  
35Cardiac Morbidity and MortalityFatal and non fatal heart failure, MI  
Suzuki, 20004.3 (1.8)13434CVD Morbidity and MortalityMI, Angina, Cerebral infarction, Cerebral hemorrhage, TIA, Sudden death, Heart failure, Renal failureAge, Gender, Smoking, Diabetes, LVH, Prior CVDABP better than Clinic BP, by stepwise regression analyses
Verdecchia, c 19943.2139289CVD Morbidity and MortalityMI, Stroke, Sudden death, Heart failure, Stroke, TIA, Coronary revascularization, Angina, Ischemic changes on ECG, Aortoiliac occlusive disease, Retinal artery occlusion, Renal failureAge, Diabetes, Prior CVD, Pulse Pressure, Clinic DBP, Smoking, Cholesterol, BMI, LVHNot tested
Verdecchia, c 19983.8 (2.4)201036CVD Morbidity and MortalityNew onset coronary artery disease, Stroke, TIA, Aortoiliac occlusive disease, Retinal artery occlusion, Heart failure, Renal failureAge, Gender, Smoking, BMI, Smoking, Cholesterol, BP medications, LVHABP better than Clinic BP, by stepwise regression analyses
Zweiker, 19942.61164Total MortalityTotal mortality Not tested
 5CVD Morbidity and MortalityMI, Apoplexy, TIA  
a

One of two papers from Syst-Eur trial

b

One of three papers from Ohasama study

c

One of the two papers from PIUMA study

From: Evidence Tables

Cover of Utility of Blood Pressure Monitoring Outside of the Clinic Setting
Utility of Blood Pressure Monitoring Outside of the Clinic Setting.
Evidence Reports/Technology Assessments, No. 63.
Appel LJ, Robinson KA, Guallar E.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.